
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $665.6M | -- | -- | $1.59 | -- |
08/07/2025 | Q2 | $650M | -- | -- | $1.50 | -- |
05/08/2025 | Q1 | $618.2M | $611.7M | $1.21 | $1.09 | $0.12 |
02/05/2025 | Q4 | $637.6M | $632.4M | $1.49 | $1.19 | $0.30 |
11/13/2024 | Q3 | $641.2M | $659.7M | $1.29 | $1.18 | $0.11 |
08/07/2024 | Q2 | $688.9M | $647.8M | $0.84 | $1.31 | -$0.47 |
05/08/2024 | Q1 | $625.2M | $672.9M | $1.28 | $0.84 | $0.44 |
02/07/2024 | Q4 | $595.9M | $643.2M | $0.82 | $0.74 | $0.08 |
11/15/2023 | Q3 | -- | -- | $0.79 | $0.96 | -$0.17 |
08/02/2023 | Q2 | -- | -- | $0.90 | $0.94 | -$0.04 |
05/03/2023 | Q1 | -- | -- | -$1.17 | $0.66 | -$1.83 |
01/31/2023 | Q4 | -- | -- | $0.88 | $0.81 | $0.07 |
11/16/2022 | Q3 | -- | -- | -$8.00 | $0.78 | -$8.78 |
07/28/2022 | Q2 | -- | -- | $2.60 | $0.98 | $1.62 |
04/28/2022 | Q1 | -- | -- | $1.23 | $0.32 | $0.91 |
02/01/2022 | Q4 | -- | -- | $0.36 | $0.12 | $0.24 |
11/16/2021 | Q3 | -- | -- | $0.30 | $0.45 | -$0.15 |
07/29/2021 | Q2 | -- | -- | $0.31 | $0.40 | -$0.09 |
04/29/2021 | Q1 | -- | -- | $0.32 | $0.30 | $0.02 |
01/28/2021 | Q4 | -- | -- | $0.55 | $0.34 | $0.21 |
11/12/2020 | Q3 | -- | -- | $0.43 | $0.41 | $0.02 |
07/30/2020 | Q2 | -- | -- | $0.50 | $0.13 | $0.37 |
04/28/2020 | Q1 | -- | -- | $0.02 | $0.19 | -$0.17 |
01/30/2020 | Q4 | -- | -- | $0.24 | $0.21 | $0.03 |
11/13/2019 | Q3 | -- | -- | $0.37 | $0.33 | $0.04 |
08/01/2019 | Q2 | -- | -- | $0.31 | $0.27 | $0.04 |
05/02/2019 | Q1 | -- | -- | -$0.03 | $0.12 | -$0.15 |
01/31/2019 | Q4 | -- | -- | $0.21 | $0.08 | $0.13 |
11/14/2018 | Q3 | -- | -- | -$0.04 | $0.36 | -$0.40 |
08/01/2018 | Q2 | -- | -- | $0.14 | -- | -- |
05/03/2018 | Q1 | -- | -- | $2.11 | -- | -- |
01/31/2018 | Q4 | -- | -- | $0.72 | -- | -- |
11/16/2017 | Q3 | -- | -- | -$0.29 | -- | -- |
08/02/2017 | Q2 | -- | -- | $0.22 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.12 | -- | -- |
01/31/2017 | Q4 | -- | -- | $0.29 | -- | -- |
11/16/2016 | Q3 | -- | -- | $0.18 | -- | -- |
08/03/2016 | Q2 | -- | -- | $0.18 | -- | -- |
05/04/2016 | Q1 | -- | -- | $0.14 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.24 | -- | -- |
11/12/2015 | Q3 | -- | -- | $0.24 | -- | -- |
Griffon reported $611.7M worth of top line sales in its most recent quarter.
Griffon announced earnings per share of $1.21 which represents a beat of analyst forecast a $1.09 per share.
Griffon reported $252.2M that represents $5.38 per share over the last quarter.
Griffon's earnings are forecast to grow from $4.23 per share to $4.84 per share next year representing an increase of 34.79%.
Griffon's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.